Literature DB >> 14714115

Alcoholism-related phenotypes and genetic variants of the CB1 receptor.

U W Preuss1, G Koller, P Zill, B Bondy, M Soyka.   

Abstract

OBJECTIVE: Neurotransmitter release of GABAergic and glutamatergic neurons may be significantly influenced by cannabinoid CB1 receptors located at presynaptic nerve terminals. GABA and glutamate have been reported to be involved in the pathogenesis of severe alcohol withdrawal-induced seizures and delirium tremens. The aim of this study is to test the potential influence of a bi-allelic cannabinoid receptor gene (CNR1) polymorphism (G1359A) on severe alcohol withdrawal syndromes.
METHODS: Based upon a sample size estimation, 196 subjects meeting DSM IV and ICD10 criteria for alcohol dependence and 210 non-alcoholic controls were recruited for study. CB1 polymorphisms were determined using polymerase chain reaction (PCR). History of alcohol withdrawal-induced delirium tremens, seizures and other alcohol withdrawal-related phenotypes were obtained using the SSAGA (Semi-Structured Assessment of Genetics in Alcoholism). Data were corroborated with information from the inpatients' clinical files.
RESULTS: Allele frequencies of the CNR1 G1359A polymorphism were within the range reported by previous studies. After correcting for multiple testing, no association of the A- or G-allele of CNR1 polymorphism with a history of alcohol withdrawal-induced seizures was detected. In addition, no significant relationships with other alcoholism-related phenotypes were found.
CONCLUSION: This study failed to confirm an earlier report of a potential role of a CNR1 polymorphism in the pathogenesis of delirium tremens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14714115     DOI: 10.1007/s00406-003-0440-7

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  10 in total

1.  Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala.

Authors:  Florence P Varodayan; Michal Bajo; Neeraj Soni; George Luu; Samuel G Madamba; Paul Schweitzer; Marisa Roberto
Journal:  Addict Biol       Date:  2016-01-20       Impact factor: 4.280

Review 2.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

3.  Parent and peer influences on emerging adult substance use disorder: A genetically informed study.

Authors:  Kaitlin Bountress; Laurie Chassin; Kathryn Lemery-Chalfant
Journal:  Dev Psychopathol       Date:  2016-01-12

Review 4.  A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.

Authors:  Matthew J Pava; John J Woodward
Journal:  Alcohol       Date:  2012-03-27       Impact factor: 2.405

5.  Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1.

Authors:  D Proudnikov; T Kroslak; J C Sipe; M Randesi; D Li; S Hamon; A Ho; J Ott; M J Kreek
Journal:  Pharmacogenomics J       Date:  2009-12-15       Impact factor: 3.550

6.  Detection of alcohol consumption in suicides.

Authors:  Barbara Schneider; Axel Schnabel; Dieter Sargk; Konrad Maurer; Bernhard Weber; Tilman Wetterling
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-19       Impact factor: 5.270

7.  Association Study of Two Cannabinoid Receptor Genes, CNR1 and CNR2, with Methamphetamine Dependence.

Authors:  Y Okahisa; M Kodama; M Takaki; T Inada; N Uchimura; M Yamada; N Iwata; M Iyo; I Sora; N Ozaki; H Ujike
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

8.  The incentive salience of alcohol: translating the effects of genetic variant in CNR1.

Authors:  Kent E Hutchison; Heather Haughey; Michelle Niculescu; Joe Schacht; Alan Kaiser; Jerry Stitzel; William J Horton; Francesca Filbey
Journal:  Arch Gen Psychiatry       Date:  2008-07

9.  Dysfunctional nitric oxide signalling increases risk of myocardial infarction.

Authors:  Jeanette Erdmann; Klaus Stark; Ulrike B Esslinger; Philipp Moritz Rumpf; Doris Koesling; Cor de Wit; Frank J Kaiser; Diana Braunholz; Anja Medack; Marcus Fischer; Martina E Zimmermann; Stephanie Tennstedt; Elisabeth Graf; Sebastian Eck; Zouhair Aherrahrou; Janja Nahrstaedt; Christina Willenborg; Petra Bruse; Ingrid Brænne; Markus M Nöthen; Per Hofmann; Peter S Braund; Evanthia Mergia; Wibke Reinhard; Christof Burgdorf; Stefan Schreiber; Anthony J Balmforth; Alistair S Hall; Lars Bertram; Elisabeth Steinhagen-Thiessen; Shu-Chen Li; Winfried März; Muredach Reilly; Sekar Kathiresan; Ruth McPherson; Ulrich Walter; Jurg Ott; Nilesh J Samani; Tim M Strom; Thomas Meitinger; Christian Hengstenberg; Heribert Schunkert
Journal:  Nature       Date:  2013-11-10       Impact factor: 49.962

Review 10.  Biomarkers of the Endocannabinoid System in Substance Use Disorders.

Authors:  Francisco Navarrete; María S García-Gutiérrez; Ani Gasparyan; Daniela Navarro; Francisco López-Picón; Álvaro Morcuende; Teresa Femenía; Jorge Manzanares
Journal:  Biomolecules       Date:  2022-03-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.